117 related articles for article (PubMed ID: 28662275)
1. Childhood cancer chemotherapy-induced bone damage: pathobiology and protective effects of resveratrol and other nutraceuticals.
Su YW; Chen KM; Hassanshahi M; Tang Q; Howe PR; Xian CJ
Ann N Y Acad Sci; 2017 Sep; 1403(1):109-117. PubMed ID: 28662275
[TBL] [Abstract][Full Text] [Related]
2. Potential Effects of Phytoestrogen Genistein in Modulating Acute Methotrexate Chemotherapy-Induced Osteoclastogenesis and Bone Damage in Rats.
King TJ; Shandala T; Lee AM; Foster BK; Chen KM; Howe PR; Xian CJ
Int J Mol Sci; 2015 Aug; 16(8):18293-311. PubMed ID: 26258775
[TBL] [Abstract][Full Text] [Related]
3. Prevention of bone growth defects, increased bone resorption and marrow adiposity with folinic acid in rats receiving long-term methotrexate.
Fan CM; Foster BK; Hui SK; Xian CJ
PLoS One; 2012; 7(10):e46915. PubMed ID: 23071661
[TBL] [Abstract][Full Text] [Related]
4. Effects of Resveratrol Supplementation on Methotrexate Chemotherapy-Induced Bone Loss.
Lee AM; Shandala T; Soo PP; Su YW; King TJ; Chen KM; Howe PR; Xian CJ
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28282956
[TBL] [Abstract][Full Text] [Related]
5. Dietary emu oil supplementation suppresses 5-fluorouracil chemotherapy-induced inflammation, osteoclast formation, and bone loss.
Raghu Nadhanan R; Abimosleh SM; Su YW; Scherer MA; Howarth GS; Xian CJ
Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1440-9. PubMed ID: 22436700
[TBL] [Abstract][Full Text] [Related]
6. Fish oil in comparison to folinic acid for protection against adverse effects of methotrexate chemotherapy on bone.
Raghu Nadhanan R; Fan CM; Su YW; Howe PR; Xian CJ
J Orthop Res; 2014 Apr; 32(4):587-96. PubMed ID: 24346859
[TBL] [Abstract][Full Text] [Related]
7. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
[TBL] [Abstract][Full Text] [Related]
8. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss.
Shandala T; Shen Ng Y; Hopwood B; Yip YC; Foster BK; Xian CJ
J Cell Physiol; 2012 Jul; 227(7):2889-97. PubMed ID: 21938727
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation.
King TJ; Georgiou KR; Cool JC; Scherer MA; Ang ES; Foster BK; Xu J; Xian CJ
Am J Pathol; 2012 Jul; 181(1):121-9. PubMed ID: 22642908
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children.
Fan C; Georgiou KR; King TJ; Xian CJ
J Biomed Biotechnol; 2011; 2011():903097. PubMed ID: 21541196
[TBL] [Abstract][Full Text] [Related]
11. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling.
Ming LG; Chen KM; Xian CJ
J Cell Physiol; 2013 Mar; 228(3):513-21. PubMed ID: 22777826
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.
Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D
Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow.
Georgiou KR; Scherer MA; Fan CM; Cool JC; King TJ; Foster BK; Xian CJ
J Cell Physiol; 2012 Mar; 227(3):909-18. PubMed ID: 21503894
[TBL] [Abstract][Full Text] [Related]
14. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
15. Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis.
Fan C; Foster BK; Wallace WH; Xian CJ
Curr Mol Med; 2011 Mar; 11(2):140-51. PubMed ID: 21342129
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-induced bone marrow adiposity is mitigated by folinic acid supplementation through the regulation of Wnt/β-catenin signalling.
Georgiou KR; Nadhanan RR; Fan CM; Xian CJ
J Cell Physiol; 2015 Mar; 230(3):648-56. PubMed ID: 25187349
[TBL] [Abstract][Full Text] [Related]
17. Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Protects Against Adriamycin and Cyclophosphamide Chemotherapy-Induced Bone Marrow Damage in Female Rats.
Fan CM; Su YW; Howe PR; Xian CJ
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415482
[TBL] [Abstract][Full Text] [Related]
18. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
[TBL] [Abstract][Full Text] [Related]
19. Multi-drug resistance protein (Mrp) 3 may be involved in resveratrol protection against methotrexate-induced testicular damage.
El-Sheikh AA; Morsy MA; Al-Taher AY
Life Sci; 2014 Dec; 119(1-2):40-6. PubMed ID: 25445225
[TBL] [Abstract][Full Text] [Related]
20. Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects.
Xian CJ; Cool JC; Scherer MA; Macsai CE; Fan C; Covino M; Foster BK
Bone; 2007 Nov; 41(5):842-50. PubMed ID: 17884747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
